These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 36968232)

  • 1. Using a shared parameter mixture model to estimate change during treatment when termination is related to recovery speed.
    Gottfredson NC; Bauer DJ; Baldwin SA; Okiishi JC
    J Consult Clin Psychol; 2014 Oct; 82(5):813-27. PubMed ID: 24274626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantable Subcutaneous Tumor Models.
    Kranjc Brezar S
    Methods Mol Biol; 2024; 2773():67-76. PubMed ID: 38236537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical classification of treatment responses in mouse clinical trials for stratified medicine in oncology drug discovery.
    Savel H; Meyer-Losic F; Proust-Lima C; Richert L
    Sci Rep; 2024 Jan; 14(1):934. PubMed ID: 38195626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived xenografts (PDXs) as model systems for human cancer.
    Invrea F; Rovito R; Torchiaro E; Petti C; Isella C; Medico E
    Curr Opin Biotechnol; 2020 Jun; 63():151-156. PubMed ID: 32070860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models.
    Savel H; Barbier S; Proust-Lima C; Rondeau V; Thiébaut R; Meyer-Losic F; Richert L
    Cancer Res Commun; 2023 Jan; 3(1):140-147. PubMed ID: 36968232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal and time-to-drop-out joint models can lead to seriously biased estimates when the drop-out mechanism is at random.
    Thomadakis C; Meligkotsidou L; Pantazis N; Touloumi G
    Biometrics; 2019 Mar; 75(1):58-68. PubMed ID: 30357814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment effects in randomized longitudinal trials with different types of nonignorable dropout.
    Yang M; Maxwell SE
    Psychol Methods; 2014 Jun; 19(2):188-210. PubMed ID: 24079928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials.
    Touraine C; Cuer B; Conroy T; Juzyna B; Gourgou S; Mollevi C
    BMC Med Res Methodol; 2023 Feb; 23(1):36. PubMed ID: 36765307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical results in longitudinal studies depended on target of inference and assumed mechanism of attrition.
    Jones M; Mishra GD; Dobson A
    J Clin Epidemiol; 2015 Oct; 68(10):1165-75. PubMed ID: 25920943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased estimation with shared parameter models in the presence of competing dropout mechanisms.
    Vonesh EF; Greene T
    Biometrics; 2022 Mar; 78(1):399-406. PubMed ID: 33592109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring a model-based analysis of patient derived xenograft studies in oncology drug development.
    Dickinson J; de Matas M; Dickinson PA; Mistry HB
    PeerJ; 2021; 9():e10681. PubMed ID: 33569251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.
    Evrard YA; Srivastava A; Randjelovic J; Doroshow JH; Dean DA; Morris JS; Chuang JH;
    Cancer Res; 2020 Jun; 80(11):2286-2297. PubMed ID: 32152150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design, analysis and application of mouse clinical trials in oncology drug development.
    Guo S; Jiang X; Mao B; Li QX
    BMC Cancer; 2019 Jul; 19(1):718. PubMed ID: 31331301
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.